HL-A antigenic loss in malignant transformation.
D000483:Alleles; D000941:Antigens; D002471:Cell Transformation, Neoplastic / Q000276:immunology*; D046508:Culture Techniques; D004247:DNA / Q000096:biosynthesis; D005347:Fibroblasts; D005838:Genotype; D006689:Hodgkin Disease / Q000097:blood / Q000235:genetics / Q000276:immunology*; D006801:Humans; D007519:Isoantigens; D037102:Lectins / Q000494:pharmacology; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010375:Pedigree; D010641:Phenotype; D012313:RNA / Q000096:biosynthesis; D012867:Skin; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014529:Uridine / Q000378:metabolism
D000941:Antigens; D007519:Isoantigens; D037102:Lectins; D014316:Tritium; D012313:RNA; D004247:DNA; D013936:Thymidine; D014529:Uridine